Affluent Medical SA (FR:AFME) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Affluent Medical, a French medtech firm, has detailed its share capital and voting rights while outlining its goals to lead in structural heart diseases and urinary incontinence treatments. The company, which is developing innovative, minimally invasive implants, plans to market its products by 2026 contingent on successful clinical trials and funding. The latest share count stands at 39,348,021 with 55,586,576 theoretical voting rights and 55,412,507 exercisable voting rights.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.